相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Immune-related adverse events in various organs caused by immune checkpoint inhibitors
Naoko Okiyama et al.
ALLERGOLOGY INTERNATIONAL (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
ATP-Responsive Smart Hydrogel Releasing Immune Adjuvant Synchronized with Repeated Chemotherapy or Radiotherapy to Boost Antitumor Immunity
Lele Sun et al.
ADVANCED MATERIALS (2021)
Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy
Jing Liu et al.
NATURE COMMUNICATIONS (2021)
Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
Yonghyun Lee et al.
NATURE MATERIALS (2020)
Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability
Nicholas G. Lamson et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Advances in oral peptide therapeutics
Daniel J. Drucker
NATURE REVIEWS DRUG DISCOVERY (2020)
Materials for oral delivery of proteins and peptides
Tyler D. Brown et al.
NATURE REVIEWS MATERIALS (2020)
Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatment
Kyung Hwan Kim et al.
ONCOIMMUNOLOGY (2020)
Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls
Eli P. Darnell et al.
CURRENT ONCOLOGY REPORTS (2020)
Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions
Xiangfei Han et al.
NATURE NANOTECHNOLOGY (2020)
The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors
Xiao-Hui Jia et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fucikova et al.
CELL DEATH & DISEASE (2020)
An ingestible self-orienting system for oral delivery of macromolecules
Alex Abramson et al.
SCIENCE (2019)
Toxicity patterns associated with chemotherapy/immune checkpoint inhibitor combinations: a meta-analysis
Omar Abdel-Rahman
IMMUNOTHERAPY (2019)
Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer
Xiangsheng Liu et al.
ACS NANO (2019)
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Qian Chen et al.
NATURE NANOTECHNOLOGY (2019)
Current Advances in Chitosan Nanoparticles Based Drug Delivery and Targeting
Unnati Garg et al.
ADVANCED PHARMACEUTICAL BULLETIN (2019)
Ionic liquids for oral insulin delivery
Amrita Banerjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
Wantong Song et al.
NATURE COMMUNICATIONS (2018)
Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses
Yu Chao et al.
NATURE BIOMEDICAL ENGINEERING (2018)
High response rate to PD-1 blockade in desmoplastic melanomas
Zeynep Eroglu et al.
NATURE (2018)
Layered defense: how mucus and tight junctions seal the intestinal barrier
Christopher T. Capaldo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
Contractile forces at tricellular contacts modulate epithelial organization and monolayer integrity
Julie Salomon et al.
NATURE COMMUNICATIONS (2017)
Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
Jianqin Lu et al.
NATURE COMMUNICATIONS (2017)
Oral delivery of macromolecular drugs: Where we are after almost 100 years of attempts
Elena Moroz et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Co-delivery of chemotherapeutics and proteins for synergistic therapy
Chaoliang He et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors A Review
Claire F. Friedman et al.
JAMA ONCOLOGY (2016)
Safety concerns over the use of intestinal permeation enhancers: A mini-review
Fiona McCartney et al.
TISSUE BARRIERS (2016)
Nanotopography Facilitates in Vivo Transdermal Delivery of High Molecular Weight Therapeutics through an Integrin-Dependent Mechanism
Laura Walsh et al.
NANO LETTERS (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma
John C. Castle et al.
BMC GENOMICS (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Regulation of intestinal epithelial permeability by tight junctions
Takuya Suzuki
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Validation of a Static Franz Diffusion Cell System for In Vitro Permeation Studies
Shiow-Fern Ng et al.
AAPS PHARMSCITECH (2010)
Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes
Christoph Kapitza et al.
DIABETES CARE (2010)
Safe and effective permeation enhancers for oral drug delivery
Kathryn Whitehead et al.
PHARMACEUTICAL RESEARCH (2008)
Challenges for the oral delivery of macromolecules
M Goldberg et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase
A Murányi et al.
BIOCHEMICAL JOURNAL (2002)
分享论文
